Abstract
Color vision testing is often considered a resource-intensive examination, requiring an anomaloscope, or at least color plates and specialized lighting equipment. Multiple novel, digital color vision testing algorithms have also been described, but were only verified using calibrated displays. In this work, we assessed if color vision testing could be performed with any computer display using two arrangement type color vision tests, the D15 and desaturated D15 panels. Established mathematical models of human color vision deficiencies (CVDs) and publicly available colorimetric data of real world computer screens were used to model how the panel colors would be displayed on computer screens and then perceived and arranged by subjects with varying levels of CVD. A total of 627,431 arrangements were evaluated. We found that all of the modeled displays, including ones with a low color accuracy of deltaE=6, were characterized by specificity above 86%, and the sensitivity of the desaturated D15 panel remained above 85% as well, with negative predictive values above 90% to detect any form of CVD compared to using the unmodifed colors. These findings suggest that any digital screen could be utilized for color vision screening, even without calibration, enabling reliable high-throughput screening utilizing equipment that is already present at virtually all healthcare providers. Since 8% of the population is affected by some form of CVD, simplifeid screening would unlock notable benefits for all stakeholders. Furthermore, the described algorithm could also be used to optimize other digital color vision tests for general use.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the University Research Scholarship Program of the Ministry for Innovation and Technology through the University of Szeged
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data can be reproduced using the code uploaded to the project repository.
